Potential proinflammatory effects of hydroxyapatite nanoparticles on endothelial cells in a monocyte-endothelial cell coculture model

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 1261-1273

  Liu, Xin ^a   Sun, Jiao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Coculture; Endothelial cells; Hydroxyapatite nanoparticles; Inflammation; Monocytes

Indexed keywords

CELL ADHESION MOLECULE; HYDROXYAPATITE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; NANOPARTICLE; BIOMATERIAL; CYTOKINE;

ARTICLE; BIOCOMPATIBILITY; CELL ACTIVATION; CELL DAMAGE; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MONOCYTE; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; ACTIVE TRANSPORT; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; NANOMEDICINE; NANOTECHNOLOGY; SIGNAL TRANSDUCTION;

BIOCOMPATIBLE MATERIALS; BIOLOGICAL TRANSPORT, ACTIVE; CELL ADHESION MOLECULES; CELL LINE; CELL SURVIVAL; COCULTURE TECHNIQUES; CYTOKINES; DURAPATITE; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; MONOCYTES; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY; SIGNAL TRANSDUCTION;

EID: 84896057954     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S56298     Document Type: Article

References (49)

1. Aulakh TS, Jayasekera N, Kuiper JH, Richardson JB. Long-term clinical outcomes following the use of synthetic hydroxyapatite and bone graft in impaction in revision hip arthroplasty. Biomaterials. 2009;30(9):1732-1738.
2. Zhou H, Lee J. Nanoscale hydroxyapatite particles for bone tissue engineering. Acta Biomater. 2011;7(7):2769-2781.
3. Fox K, Tran PA, Tran N. Recent advances in research applications of nanophase hydroxyapatite. Chemphyschem. 2012;13(10):2495-2506.
4. Kadono H, Furuzono T, Masuda M, et al. In vivo evaluation of hydroxyapatite nanocoating on polyester artificial vascular grafts and possibility as soft-tissue compatible material. ASAIO J. 2010;56(1):61-66.
5. Ashokan A, Chandran P, Sadanandan AR, et al. Development and haematotoxicological evaluation of doped hydroxyapatite based multimodal nanocontrast agent for near-infrared, magnetic resonance and X-ray contrast imaging. Nanotoxicology. 2012;6(6):652-666.
6. Uskokoví V, Uskoković DP. Nanosized hydroxyapatite and other calcium phosphates: chemistry of formation and application as drug and gene delivery agents. J Biomed Mater Res B Appl Biomater. 2011;96(1): 152-191.
7. Donaldson KI, Duffin R, Langrish JP, et al. Nanoparticles and the cardiovascular system: a critical review. Nanomedicine (Lond). 2013;8(3):403-423.
8. Kristovich R, Knight DA, Long JF, Williams MV, Dutta PK, Waldman WJ. Macrophage-mediated endothelial inflammatory responses to airborne particulates: impact of particulate physicochemical properties. Chem Res Toxicol. 2004;17(10):1303-1312.
9. Weldy CS, Wilkerson HW, Larson TV, Stewart JA, Kavanagh TJ. {Eth}IESEL particulate exposed macrophages alter endothelial cell expression of eNOS, iNOS, MCP1, and glutathione synthesis genes. Toxicol In Vitro. 2011;25(8):2064-2073.
10. Shaw CA, Robertson S, Miller MR, et al. Diesel exhaust particulate-exposed macrophages cause marked endothelial cell activation. Am J Respir Cell Mol Biol. 2011;44(6):840-851.
11. Liu X, Xue Y, Ding T, Sun J. Enhancement of proinflammatory and procoagulant responses to silica particles by monocyte-endothelial cell interactions. Part Fibre Toxicol. 2012;9:36.
12. Nadra I, Boccaccini AR, Philippidis P, et al. Effect of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by macrophages. Atherosclerosis. 2008;196(1):98-105.
13. Scheel J, Weimans S, Thiemann A, Heisler E, Hermann M. Exposure of the murine RAW 264.7 macrophage cell line to hydroxyapatite dispersions of various composition and morphology: assessment of cytotoxicity, activation and stress response. Toxicol In Vitro. 2009;23(3):531-538.
14. Grandjean-Laquerriere A, Tabary O, Jacquot J, et al. Involvement of tolllike receptor 4 in the inflammatory reaction induced by hydroxyapatite particles. Biomaterials. 2007;28(3):400-404.
15. Motskin M, Wright DM, Muller K, et al. Hydroxyapatite nano and microparticles: correlation of particle properties with cytotoxicity and biostability. Biomaterials. 2009;30(19):3307-3317.
16. Okada M, Masuda M, Tanaka R, Miyatake K, Kuroda D, Furuzono T. Preparation of hydroxyapatite-nanocrystal-coated stainless steel, and its cell interaction. J Biomed Mater Res A. 2008;86(3):589-596.
17. Pezzatini S, Morbidelli L, Solito R, et al. Nanostructured HA crystals up-regulate FGF-2 expression and activity in microvascular endothelium promoting angiogenesis. Bone. 2007;41(4):523-534.
18. Zhao X, Ng S, Heng BC, et al. Cytotoxicity of hydroxyapatite nanoparticles is shape and cell dependent. Arch Toxicol. 2013;87(6): 1037-1052.
19. Xie G, Sun J, Zhong G, Liu C, Wei J. Hydroxyapatite nanoparticles as a controlled-release carrier of BMP-2: absorption and release kinetics in vitro. J Mater Sci Mater Med. 2010;21(6):1875-1880.
20. Liu X, Sun J. Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways. Biomaterials. 2010;31(32):8198-8209.
21. Kang M, Lim CH, Han JH. Comparison of toxicity and deposition of nano-sized carbon black aerosol prepared with or without dispersing sonication. Toxicol Res. 2013;29(2):121-127.
22. Zhao X, Heng BC, Xiong S, et al. In vitro assessment of cellular responses to rod-shaped hydroxyapatite nanoparticles of varying lengths and surface areas. Nanotoxicology. 2011;5(2):182-194.
23. Xu Z, Liu C, Wei J, Sun J. Effects of four types of hydroxyapatite nanoparticles with different nanocrystal morphologies and sizes on apoptosis in rat osteoblasts. J Appl Toxicol. 2012;32(6):429-435.
24. Clift MJ, Gehr P, Rothen-Rutishauser B. Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative. Arch Toxicol. 2011;85(7):723-731.
25. Wan R, Mo Y, Zhang X, Chien S, Tollerud DJ, Zhang Q. Matrix metalloproteinase-2 and-9 are induced differently by metal nanoparticles in human monocytes: The role of oxidative stress and protein tyrosine kinase activation. Toxicol Appl Pharmacol. 2008;233(2): 276-285.
26. Oh WK, Kim S, Choi M, et al. Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality. ACS Nano. 2010;4(9):5301-5313.
27. Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci (Lond). 2005;108(3):205-213.
28. Dessein PH, Joffe BI, Singh S. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther. 2005;7(3):R634-R643.
29. Hou T, Tieu BC, Ray S, et al. Roles of IL-6-gp130 signaling in vascular inflammation. Curr Cardiol Rev. 2008;4(3):179-192.
30. Pu FR, Williams RL, Markkula TK, Hunt JA. Expression of leukocyteendothelial cell adhesion molecules on monocyte adhesion to human endothelial cells on plasma treated PET and PTFE in vitro. Biomaterials. 2002;23(24):4705-4718.
31. Rose SL, Babensee JE. Procoagulant phenotype of endothelial cells after coculture with biomaterial-treated blood cells. J Biomed Mater Res A. 2005;72(3):269-278.
32. Martinesi M, Bruni S, Stio M, Treves C, Bacci T, Borgioli F. Biocompatibility evaluation of surface-treated AISI 316L austenitic stainless steel in human cell cultures. J Biomed Mater Res A. 2007;80(1): 131-145.
33. McDonald SM, Matheson LA, McBane JE, et al. Use of monocyte/ endothelial cell co-cultures (in vitro) and a subcutaneous implant mouse model (in vivo) to evaluate a degradable polar hydrophobic ionic polyurethane. J Cell Biochem. 2011;112(12):3762-3772.
34. Liu X, Xue Y, Sun J. Indirect induction of endothelial cell injury by PUor PTFE-mediated activation of monocytes. J Biomater Sci Polym Ed. 2010;21(13):1783-1797.
35. Schanen BC, Karakoti AS, Seal S, Drake DR 3rd, Warren WL, Self WT. Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. ACS Nano. 2009;3(9):2523-2532.
36. Herseth J, Refsnes M, Låg M, Hetland G, Schwarze P. IL-1beta as a determinant in silica-induced cytokine responses in monocyteendothelial cell co-cultures. Hum Exp Toxicol. 2008;27(5):387-399.
37. Napierska D, Thomassen LC, Vanaudenaerde B, et al. Cytokine production by co-cultures exposed to monodisperse amorphous silica nanoparticles: the role of size and surface area. Toxicol Lett. 2012;211(2):98-104.
38. Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep. 2009;61(1):22-32.
39. Muslin AJ. MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin Sci (Lond). 2008;115(7):203-218.
40. Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med. 2008;18(6): 228-232.
41. Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation. 2002;105(5):546-549.
42. Silverman MD, Zamora DO, Pan Y, et al. Cell adhesion molecule expression in cultured human iris endothelial cells. Invest Ophthalmol Vis Sci. 2001,42(12):2861-2866.
43. Makó VI, Czúcz J, Weiszhár Z, et al. Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1β, TNF-α, and LPS. Cytometry A. 2010;77(10):962-970.
44. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol. 2002;20:55-72.
45. Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 2005;15(1):11-18.
46. Mong PY, Petrulio C, Kaufman HL, Wang Q. Activation of Rho kinase by TNF-alpha is required for JNK activation in human pulmonary microvascular endothelial cells. J Immunol. 2008;180(1):550-558.
47. Richmond A. Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol. 2002;2(9):664-674.
48. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 1995;9(10): 899-909.
49. Kuldo JM, Westra J, Asgeirsdóttir SA, et al. Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro. Am J Physiol Cell Physiol. 2005;289(5): C1229-C1239.